These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27853350)

  • 1. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study.
    Korol AR; Zadorozhnyy OS; Naumenko VO; Kustryn TB; Pasyechnikova NV
    Clin Ophthalmol; 2016; 10():2223-2229. PubMed ID: 27853350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study.
    Korol AR; Zborovska O; Kustryn T; Dorokhova O; Pasyechnikova N
    Clin Ophthalmol; 2017; 11():1315-1320. PubMed ID: 28769551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization.
    Wang JK; Huang TL; Chang PY; Chen YT; Chang CW; Chen FT; Hsu YR; Chen YJ
    Sci Rep; 2018 Sep; 8(1):14389. PubMed ID: 30258077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M; Allievi F; Mazzeo L; Gabrieli CB
    Am J Ophthalmol; 2009 Jan; 147(1):84-93.e1. PubMed ID: 18774547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.
    Ikuno Y; Ohno-Matsui K; Wong TY; Korobelnik JF; Vitti R; Li T; Stemper B; Asmus F; Zeitz O; Ishibashi T;
    Ophthalmology; 2015 Jun; 122(6):1220-7. PubMed ID: 25745875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study.
    Bruè C; Pazzaglia A; Mariotti C; Reibaldi M; Giovannini A
    Eye (Lond); 2016 Jan; 30(1):139-45. PubMed ID: 26514244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for treatment of myopic choroidal neovascularization: the second year of a prospective study.
    Gharbiya M; Allievi F; Conflitti S; Esposito M; Scavella V; Moramarco A; Cruciani F
    Clin Ter; 2010; 161(3):e87-93. PubMed ID: 20589348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal aflibercept for myopic choroidal neovascularization.
    Pece A; Milani P
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2327-2332. PubMed ID: 27286893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
    Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
    Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
    Pitcher JD; Witkin AJ; DeCroos FC; Ho AC
    Br J Ophthalmol; 2015 Jun; 99(6):848-52. PubMed ID: 25595177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes.
    Sarao V; Veritti D; Macor S; Lanzetta P
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):445-54. PubMed ID: 26084446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab for the treatment of choroidal neovascularizations associated with pathologic myopia: a prospective study.
    Pasyechnikova NV; Naumenko VO; Korol AR; Zadorozhnyy OS; Kustryn TB; Henrich PB
    Ophthalmologica; 2015; 233(1):2-7. PubMed ID: 25501802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
    Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
    Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients.
    Yang X; Dai H
    Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.